510(k) · Cleared
ClearedRebound HRDV
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Minnesota Medical Development, Inc. · FTL Mesh, Surgical, Polymeric
Cleared on Apr 23, 2009 as substantially equivalent to K063671 (Minnesota Medical Development, Inc., 2007) and 1 other predicate after a 150-day review. Its family tree reaches back 3 generations to 1996. 3 later devices descend from it.
- Decided
- Apr 23, 2009
- Review
- 150 days
- Class
- Class II
- Product code
- FTL
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 3 generations to K963141 (1996). 4 ancestors in all. 3 later devices descend from it, 1 citing it directly.
- Root · 3 generations backK963141 Kugel Hernia PatchDouglas Bueschel · 1996
- 2 generations backK063671 Rebound HRDMinnesota Medical Development, Inc. · 2007
- 1 generation backK080393 Modification to Rebound HRDMinnesota Medical Development, Inc. · 2008
- This deviceK083467 Rebound HRDVMinnesota Medical Development, Inc. · 2009
- Descendant · cites it directly · 2 of its ownK143743 ECHO 2.0 LAP SYSTEM with VENTRALIGHT ST MESHC.R. Bard, Inc. · 2015
- Descendant · 2 generations on · 1 of its ownK170294 VENTRALIGHT ST Mesh with ECHO 2 Positioning System 11cm (4.5”)…C. R. Bard · 2017
- Descendant · 3 generations on · 0 of its ownK182008 Phasix ST Mesh with Echo 2 Positioning SystemC.R. Bard, Inc. · 2018
Most influential descendants
Showing 3 of 3 · See all- K143743ECHO 2.0 LAP SYSTEM with VENTRALIGHT ST MESHC.R. Bard, Inc. · 2015 · cites it directly2descendants
- K170294VENTRALIGHT ST Mesh with ECHO 2 Positioning System 11cm (4.5”) Circle, VENTRALIGHT ST…C. R. Bard · 2017 · 2 generations on1descendant
- K182008Phasix ST Mesh with Echo 2 Positioning SystemC.R. Bard, Inc. · 2018 · 3 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K963141 | Kugel Hernia Patch | Douglas Bueschel | 1996 | — |
| −2 | K063671 | Rebound HRD | Minnesota Medical Development, Inc. | 2007 | — |
| −1 | K080393 | Modification to Rebound HRD | Minnesota Medical Development, Inc. | 2008 | — |
| 0 (this device) | K083467 | Rebound HRDV | Minnesota Medical Development, Inc. | 2009 | — |
| +1 | K143743 | ECHO 2.0 LAP SYSTEM with VENTRALIGHT ST MESH | C.R. Bard, Inc. | 2015 | — |
| +2 | K170294 | VENTRALIGHT ST Mesh with ECHO 2 Positioning System 11cm (4.5”) Circle… | C. R. Bard | 2017 | — |
| +3 | K182008 | Phasix ST Mesh with Echo 2 Positioning System | C.R. Bard, Inc. | 2018 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2006 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2015 | 1 | 0 |
| 2017 | 1 | 0 |
| 2018 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FTL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new FTL device
- #1 K220091 Poly-Tape/Infinity-Lock Soft Tissue…score 16.8 · 14 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K063671 | Rebound HRDSummary page 1…entified during risk analysis. Conclusion: REBOUND HRD V is substantially equivalent to the REBOUND HRDTM (K063671, K080393) in regards to the indications for use, the basic operating principle, materials, sterilization… | 2007 |
| * | K080393 | Modification to Rebound HRDSummary page 1…during risk analysis. Conclusion: REBOUND HRD V is substantially equivalent to the REBOUND HRDTM (K063671, K080393) in regards to the indications for use, the basic operating principle, materials, sterilization, packagi… | 2008 |
What descends from it? (3)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K143743 | ECHO 2.0 LAP SYSTEM with VENTRALIGHT ST MESH | 2015 | 2 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 13 years and passes through 2 companies; a new generation was cleared every 1.1 years on median.
- None of the 4 ancestors has a recall.
- Of its descendants, K143743 (C.R. Bard, Inc., 2015) has gone furthest, with 2 descendants of its own.
- 2 other devices also cite its predicate K063671.
How does its category compare?
All FTL devicesFTL Mesh, Surgical, Polymeric: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.
FDA decisions per year · FTL
6in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · FTL
30in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · FTL
1in 2020
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · FTL
3,487in 2025
MAUDE reports naming product code FTL, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 20 | 92 | 2 | 1,737 |
| 2008 | 23 | 114 | 1 | 1,569 |
| 2009 | 15 | 97 | 1 | 1,906 |
| 2010 | 18 | 132 | 12 | 2,175 |
| 2011 | 15 | 90 | 8 | 3,608 |
| 2012 | 12 | 213 | 2 | 14,700 |
| 2013 | 8 | 90 | 1 | 26,519 |
| 2014 | 11 | 70 | 3 | 2,683 |
| 2015 | 12 | 121 | 0 | 2,526 |
| 2016 | 3 | 186 | 0 | 2,417 |
| 2017 | 6 | 132 | 1 | 3,947 |
| 2018 | 12 | 105 | 1 | 11,893 |
| 2019 | 4 | 99 | 0 | 21,724 |
| 2020 | 5 | 138 | 1 | 18,819 |
| 2021 | 2 | — | 0 | 16,284 |
| 2022 | 6 | 195 | 0 | 11,439 |
| 2023 | 4 | 29 | 0 | 8,025 |
| 2024 | 2 | — | 0 | 8,565 |
| 2025 | 6 | 30 | 0 | 3,487 |
| 2026 | 2 | — | 0 | — |
What is it indicated for?
REBOUND HRD® V is intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects where weakness exists and where the support of a nonabsorbable material is preferred.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K083467 · printed Nov 4, 2026
Cite this page
510(k) Report. “K083467: Rebound HRDV.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K083467
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026